Literature DB >> 12698059

Novel insights into renal fibrosis.

Frank Eitner1, Jürgen Floege.   

Abstract

PURPOSE OF REVIEW: Renal fibrosis characterizes a common endpoint of diverse renal diseases which leads to functional impairment ultimately resulting in terminal renal failure. RECENT
FINDINGS: Recent advances in this field led to the discovery of several novel mediators as well as novel aspects of known mediators. Studies on the origin and role of specific renal cell types involved in renal fibrosis identified bone marrow derived mesangial progenitors and offered substantial evidence for the concept of epithelial to mesenchymal transition. Much progress has also been made in better understanding of the interactions between different mediators and between mediators and renal target cells. Compounds designed on the basis of this current knowledge have proven to be potent inhibitors of the development of renal fibrosis or might even induce resolution of renal fibrosis.
SUMMARY: The number and diversity of recent studies in this field offer hope for new treatment regimes in our clinical efforts towards prevention and regression of progressive fibrosing renal diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12698059     DOI: 10.1097/00041552-200305000-00002

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  7 in total

1.  Postobstructive regeneration of kidney is derailed when surge in renal stem cells during course of unilateral ureteral obstruction is halted.

Authors:  H C Park; K Yasuda; B Ratliff; A Stoessel; Y Sharkovska; I Yamamoto; J-F Jasmin; S Bachmann; M P Lisanti; P Chander; M S Goligorsky
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-11

2.  Indolent course of tubulointerstitial disease in a mouse model of subpressor, low-dose nitric oxide synthase inhibition.

Authors:  Adelina Stoessel; Alexander Paliege; Franziska Theilig; Francesco Addabbo; Brian Ratliff; Jens Waschke; Daniel Patschan; Michael S Goligorsky; Sebastian Bachmann
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-02

3.  Renal fibrosis.

Authors:  Min Hyun Cho
Journal:  Korean J Pediatr       Date:  2010-07-31

4.  Mesenchymal stem cell-derived microparticles ameliorate peritubular capillary rarefaction via inhibition of endothelial-mesenchymal transition and decrease tubulointerstitial fibrosis in unilateral ureteral obstruction.

Authors:  Hoon Young Choi; Hyun Gyu Lee; Beom Seok Kim; Sun Hee Ahn; Ara Jung; Mirae Lee; Jung Eun Lee; Hyung Jong Kim; Sung Kyu Ha; Hyeong Cheon Park
Journal:  Stem Cell Res Ther       Date:  2015-03-11       Impact factor: 6.832

Review 5.  Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling.

Authors:  Jin-Ku Lee; Kyeung Min Joo; Jeongwu Lee; Yeup Yoon; Do-Hyun Nam
Journal:  Onco Targets Ther       Date:  2014-10-20       Impact factor: 4.147

Review 6.  The Role of Platelets in Diabetic Kidney Disease.

Authors:  Ukhti Jamil Rustiasari; Joris J Roelofs
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

7.  Role of Sirolimus in renal tubular apoptosis in response to unilateral ureteral obstruction.

Authors:  Mei Yang; Yang-Yang Zhuang; Wei-Wei Wang; Hai-Ping Zhu; Yan-Jie Zhang; Sao-Ling Zheng; Yi-Rrong Yang; Bi-Cheng Chen; Peng Xia; Yan Zhang
Journal:  Int J Med Sci       Date:  2018-09-07       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.